| 
            State health department encourages cervical screenings, HPV 
			vaccination  Send a link to a friend
 
			
            
            [January 23, 2013] 
            CHICAGO -- During National 
			Cervical Awareness Month, observed every January, the Illinois 
			Department of Public Health is encouraging regular screening for 
			cervical cancer and vaccination for the human papillomavirus, known 
			as HPV, which is the leading cause of the disease. | 
		
            |  "Because of advances in screening, as well as the HPV vaccine, 
			cervical cancer is highly preventable. It is also very treatable if 
			detected early," said IDPH Director LaMar Hasbrouck. "There are 
			often no noticeable symptoms with cervical cancer, so it is 
			important to get screened regularly. Now is also the time for teens 
			and young women and men to talk with health care providers about the 
			HPV vaccine, which can prevent the most common types of HPV that 
			cause cervical cancer." All women are at risk for cervical cancer; 
			however, it occurs most often in women over age 30. About 12,000 
			women each year in the U.S. are diagnosed with cervical cancer. In 
			Illinois, it is projected that about 580 women will be diagnosed 
			with cervical cancer this year, and an estimated 160 will die of the 
			disease. 
			
			 The primary cause of cervical cancer is HPV, which is the most 
			common sexually transmitted disease. At least half of all sexually 
			active people will have HPV at some point in their lives, but 
			relatively few women will develop cervical cancer. Cervarix and Gardasil are licensed HPV vaccines for females ages 
			9-26. The Centers for Disease Control and Prevention recommends that 
			all 11- or 12-year-old girls get the three doses (shots) of either 
			brand of HPV vaccine to protect against cervical cancer. CDC also 
			recommends the vaccine for girls and women ages 13-26 who did not 
			get any or all of the doses when they were younger. 
			[to top of second column] | 
 
			 Gardasil is also licensed for males ages 9 through 26. CDC 
			recommends Gardasil for all males ages 11-21. For more information about cervical cancer screening and the 
			Illinois Breast and Cervical Cancer Program, contact IDPH’s 
			toll-free Women's Health-Line at 888-522-1282 or visit
			
			www.cancerscreening.illinois.gov. 
            [Text from 
			Illinois 
			Department of Public Health file received from 
			the
			Illinois Office of 
			Communication and Information] 
            
			 |